Which statement best describes hepatitis B treatment duration if the response is favorable?

Which statement best describes hepatitis B treatment duration if the response is favorable?

• A. Six months regardless of response
• B. As long as it works
• C. Twelve months then discontinue
• D. Until seroconversion

Answer: (B)

In treating chronic hepatitis B, the goal of antiviral therapy is sustained suppression of the virus and stabilization of liver disease. Because the virus often reappears if therapy is stopped and resistance or relapse can undermine outcomes, there isn’t a fixed end date that applies to everyone. If the response is favorable—meaning HBV DNA remains suppressed at low or undetectable levels and liver enzymes stay normal—therapy is continued to maintain that control. The duration is therefore driven by ongoing effectiveness and tolerability rather than a preset timeframe. Regular monitoring of viral load, liver tests, kidney and bone health (depending on the antiviral used), and clinical status guides whether to continue, switch agents, or, in rare cases with very durable responses, consider stopping under careful supervision.

In treating chronic hepatitis B, the goal of antiviral therapy is sustained suppression of the virus and stabilization of liver disease. Because the virus often reappears if therapy is stopped and resistance or relapse can undermine outcomes, there isn’t a fixed end date that applies to everyone. If the response is favorable—meaning HBV DNA remains suppressed at low or undetectable levels and liver enzymes stay normal—therapy is continued to maintain that control. The duration is therefore driven by ongoing effectiveness and tolerability rather than a preset timeframe. Regular monitoring of viral load, liver tests, kidney and bone health (depending on the antiviral used), and clinical status guides whether to continue, switch agents, or, in rare cases with very durable responses, consider stopping under careful supervision.